why choose us

First received: May 15, 2023

Clinical Trial: Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Glioblastoma Multiforme

Study Type: OBSERVATIONAL


Official Title: Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme

Brief Summary: This is a feasibility single arm study designed for obtaining early data for optimization and evaluation of the clinical potential for a new MR technique using deuterated glucose.The purpose of the study is to investigate whether this technique is useful in metabolic imaging of glioblastoma multiforme (GBM) and whether radiochemotherapy (RCT) induced changes in the brain metabolism can be detected and might be predictive for treatment response.The study will include 10 patients with histologically verified GBM…

Read more